139 related articles for article (PubMed ID: 17473192)
1. Association between functional EGF+61 polymorphism and glioma risk.
Costa BM; Ferreira P; Costa S; Canedo P; Oliveira P; Silva A; Pardal F; Suriano G; Machado JC; Lopes JM; Reis RM
Clin Cancer Res; 2007 May; 13(9):2621-6. PubMed ID: 17473192
[TBL] [Abstract][Full Text] [Related]
2. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1 -509C>T gene polymorphisms with gallbladder cancer.
Vishnoi M; Pandey SN; Modi DR; Kumar A; Mittal B
Hum Immunol; 2008 Jun; 69(6):360-7. PubMed ID: 18571008
[TBL] [Abstract][Full Text] [Related]
3. TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomas.
Lima-Ramos V; Pacheco-Figueiredo L; Costa S; Pardal F; Silva A; Amorim J; Lopes JM; Reis RM
Cancer Genet Cytogenet; 2008 Jan; 180(1):14-9. PubMed ID: 18068527
[TBL] [Abstract][Full Text] [Related]
4. +61A>G polymorphism in the EGF gene does not increase the risk of lung cancer.
Kang HG; Choi JE; Lee WK; Kam S; Cha SI; Kim CH; Jung TH; Park JY
Respirology; 2007 Nov; 12(6):902-5. PubMed ID: 17986122
[TBL] [Abstract][Full Text] [Related]
5. The 61 A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastoma.
Vauleon E; Auger N; Benouaich-Amiel A; Laigle-Donadey F; Kaloshi G; Lejeune J; Delattre JY; Thillet J; Sanson M
Cancer Genet Cytogenet; 2007 Jan; 172(1):33-7. PubMed ID: 17175377
[TBL] [Abstract][Full Text] [Related]
6. Ovarian cancer and genetic susceptibility: association of A61G polymorphism in the EGF gene.
Araújo AP; Ribeiro R; Pereira D; Pinto D; Sousa B; Catarino R; Medeiros R
Exp Biol Med (Maywood); 2009 Mar; 234(3):241-5. PubMed ID: 19144868
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphism in EGF is associated with prostate cancer aggressiveness and progression-free interval in androgen blockade-treated patients.
Teixeira AL; Ribeiro R; Cardoso D; Pinto D; Lobo F; Fraga A; Pina F; Calais-da-Silva F; Medeiros R
Clin Cancer Res; 2008 Jun; 14(11):3367-71. PubMed ID: 18519765
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms of EGF 5'-UTR and NAT2 857G/A associated with glioma in a case control study of Malaysian patients.
Muthusamy KA; Lian LH; Vairavan N; Chua KH; Waran V
Genet Mol Res; 2012 Aug; 11(3):2939-45. PubMed ID: 22782629
[TBL] [Abstract][Full Text] [Related]
9. Impact of EGFR genetic variants on glioma risk and patient outcome.
Costa BM; Viana-Pereira M; Fernandes R; Costa S; Linhares P; Vaz R; Pinheiro C; Lima J; Soares P; Silva A; Pardal F; Amorim J; Nabiço R; Almeida R; Alegria C; Pires MM; Pinheiro C; Carvalho E; Oliveira P; Lopes JM; Reis RM
Cancer Epidemiol Biomarkers Prev; 2011 Dec; 20(12):2610-7. PubMed ID: 21960689
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor genetic variation, breast cancer risk, and waiting time to onset of disease.
Araújo AP; Ribeiro R; Pinto D; Pereira D; Sousa B; Mauricio J; Lopes C; Medeiros R
DNA Cell Biol; 2009 May; 28(5):265-9. PubMed ID: 19388850
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor gene polymorphism is different between schizophrenia and lung cancer patients in Korean population.
Lim YJ; Kim JW; Song JY; Hong MS; Jin SY; Yoon SH; Park HJ; Choe BK; Lee JJ; Yim SV; Hong SI; Baik HH; Ha E; Park YH
Neurosci Lett; 2005 Feb; 374(3):157-60. PubMed ID: 15663953
[TBL] [Abstract][Full Text] [Related]
12. A novel functional polymorphism in the Cdc6 promoter is associated with the risk for hepatocellular carcinoma.
Xiong XD; Fang JH; Qiu FE; Zhao J; Cheng J; Yuan Y; Li SP; Zhuang SM
Mutat Res; 2008 Aug; 643(1-2):70-4. PubMed ID: 18640135
[TBL] [Abstract][Full Text] [Related]
13. The A61G EGF polymorphism is associated with development of extraaxial nervous system tumors but not with overall survival.
Almeida LO; Custódio AC; Santos MJ; Almeida JR; Clara CA; Pinto GR; Rey JA; Casartelli C
Cancer Genet Cytogenet; 2010 Apr; 198(1):15-21. PubMed ID: 20303009
[TBL] [Abstract][Full Text] [Related]
14. No association between epidermal growth factor and epidermal growth factor receptor polymorphisms and nasopharyngeal carcinoma.
Gao LB; Wei YS; Zhou B; Wang YY; Liang WB; Li C; Li Y; Bai P; Fang WL; Xue H; Zhang L
Cancer Genet Cytogenet; 2008 Sep; 185(2):69-73. PubMed ID: 18722874
[TBL] [Abstract][Full Text] [Related]
15. p53 Genotypes and risk of glioma and meningioma.
Malmer B; Feychting M; Lönn S; Ahlbom A; Henriksson R
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2220-3. PubMed ID: 16172235
[TBL] [Abstract][Full Text] [Related]
16. Rare HRAS1 alleles are a risk factor for the development of brain tumors.
Vega A; Sobrido MJ; Ruiz-Ponte C; Barros F; Carracedo A
Cancer; 2001 Dec; 92(11):2920-6. PubMed ID: 11753967
[TBL] [Abstract][Full Text] [Related]
17. Complement receptor 1 (A3650G RsaI and intron 27 HindIII) polymorphisms and risk of gallbladder cancer in north Indian population.
Srivastava A; Mittal B
Scand J Immunol; 2009 Dec; 70(6):614-20. PubMed ID: 19906204
[TBL] [Abstract][Full Text] [Related]
18. Inducible nitric oxide synthase promoter polymorphism, cigarette smoking, and urothelial carcinoma risk.
Shen CH; Wang YH; Wang WC; Jou YC; Hsu HS; Hsieh HY; Chiou HY
Urology; 2007 May; 69(5):1001-6. PubMed ID: 17482959
[TBL] [Abstract][Full Text] [Related]
19. Association between the epidermal growth factor +61 G/A polymorphism and glioma risk: a meta-analysis.
Chen X; Yang G; Zhang D; Zhang W; Zou H; Zhao H; Zhang X; Zhao S
PLoS One; 2014; 9(4):e95139. PubMed ID: 24740103
[TBL] [Abstract][Full Text] [Related]
20. The Ala allele at Val762Ala polymorphism in poly(ADP-ribose) polymerase-1 (PARP-1) gene is associated with a decreased risk of asthma in a Turkish population.
Tezcan G; Gurel CB; Tutluoglu B; Onaran I; Kanigur-Sultuybek G
J Asthma; 2009 May; 46(4):371-4. PubMed ID: 19484672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
